Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Gold Bull Resources has a Real Shot at Finding a Monster Gold Deposit

By Jay Taylor, Taylor Hard Money AdvisorsAs of March 31, 2022, Gold Bull had 9,825,000 options open with an average price of C$0.36, which if fully exercised would add $3.54 million to the treasur...

Let's Invest: Are you prepared for do-it-yourself investing?

In our fourth segment of our “Let’s Invest” series’ with Jean-Paul Bureaud, executive director of FAIR Canada , we stay on the self-investing side with DIY – do-it-yourself investing. Bureaud goes over the pros and co...

First Helium: a Canadian company exploring and developing two premier helium projects

When you think of Alberta, Helium companies may not be top of mind. But look no further, First Helium has identified many follow-up drill locations and acquired a well operating infrastructure system which will help expand future exploration programs. Consisting of t...

Mylan Gets a Shot in the Arm with Pfizer Merger Deal

EpiPen manufacturer Mylan N.V. announced today that the company will merge with Pfizer Inc.'s Upjohn Division, which holds Pfizer's off-patent branded and generic drugs, forming a new company. Mylan Inc. (MYL:NASDAQ) and Pfizer Inc. (PFE:NYSE) today anno...

Canadian Fintech RevoluGROUP targeted in the heated M&A takedown

2022 has seen its fair share of mergers and acquisitions in the Fintech world. But the year isn’t over yet; there could be yet another, and this time it’s a Canadian Fintech. A little-known...

A Deep Dig into a Very Profitable Drill Operator

(Click image to play video) Over the years, Stockhouse readers, viewers and listeners have enjoyed the opportunity to discover thousands of new and established small cap metals & mining companies…from explorers to producers to developers…and everything in-betwee...

Gold and Silver: Capitulation Time

"People everywhere are being fed propaganda, lies and false stimuli of all kinds, but deep in their hearts, deep in their instincts, they know something is wrong."—G. Edward Griffin, author of The Creature from Jekyll Island My usual weekend missive was mildly delay...

What Resource Companies Are on This Fund Manager's Buy List?

Ralph Aldis, portfolio manager at U.S. Global Investors, in this interview with Streetwise Reports, looks at precious metals during the global downturn, and discusses M&A in the industry as well as companies he sees as undervalued. Streetwise Reports: Ralph, tha...

Simple, Uncomplicated: Find Out What Natural Beauty is All About

(Click image to play video) 2020 has been a whirlwind year for Marianna Naturals Corp. ( MRNN , Forum ). Founded in April of 2020 by both Co-Founder & Chairwoman Heather Marianna and Co-Founder, President & CEO Joel DeBellefeuille as the company is ...

INmune Bio Targeting Cancer, Alzheimer's and NASH Simultaneously

We are initiating coverage on INmune Bio Inc. (INMB:NASDAQ) . According to the company, INmune is "Reprogramming the Innate Immune System for the Treatment of Diseases." On the surface, this sounds like a fairly standard biotech tagline, but there's a more here than me...
1 2 3 4 5 6 7 8 9 10 ...